Jiangsu Promotes AI Applications in Drug Target Screening, Molecular Design, and Medical Device Manufacturing
Deep News
Jan 13
The Jiangsu Provincial Government has issued a notice regarding the approval and distribution of the Jiangsu Province "Artificial Intelligence +" Action Plan. The plan emphasizes enhancing innovation capabilities in biopharmaceutical research and development. It aims to promote the application of artificial intelligence in scenarios such as drug target screening, drug molecular design, and medical device manufacturing. The initiative also includes building "AI +" public service platforms, developing expert models for synthetic biological components, small molecule drugs, and organoid evaluation, and opening up toolchains for molecular design, protein prediction, and virtual screening to small and medium-sized enterprises.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.